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Introduction 
Although acute inflammation can efficiently be treated, the treatment of chronic inflammatory pathologies is still a 
challenge to rise. As marker of inflammation, the enzyme Myeloperoxidase (MPO) is a choice target for the 
establishment of a treatment. Indeed, the uncontrolled release in the extracellular medium of MPO, marker of 
inflammation, along with the release of ROS, causes severe damages on biological tissues. The modulation of the 
enzyme activity, by an inhibitor, might constitute an approach to treat excessive inflammation. An interesting 
pathway is to give a second life to clinical-used molecules, presenting antioxidant and anti-inflammatory properties. 
According to several studies, morphine and propofol (PPF), which are already known for their analgesic and 
anesthetic properties, present an antioxidant activity. Therefore, these reducing molecule can potentially pretend to be 
MPO inhibitors.  
 
Aims of the study 
- Evaluate the potential reducing and anti-catalytic actions of morphine and PPF on the similar peroxidase 
activity of two enzymes : MPO and HRP, with two complementary  techniques: EPR and docking 
- Compare the activity of morphine and PPF versus two polyphenols, quercetin and gallic acid, and ascorbic 
acid  
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Fig.2: Scheme of the peroxydase cycle of  a  
peroxidase  enzyme triggered by the interaction with its 
natural substrate H2O2 or with a reducing substrate AH2  
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Fig.3: Action of the antioxidant 
compounds on the ABTS . +  radical. The 
radical is formed by the oxidation of 
ABTS by the peroxidase cycle of HRP. 
The percentages of inhibition of MPO activity for each 
molecules were calculated versus their respective 
solvent control. Data are given as mean ± SD (n≥ 5).                       
( [HRP]=3,41 10-7 M, [H2O2]=4,85 10
-5 M, [ABTS]=6,75 
10-5 M, in phosphate buffer pH 7.4).  
 
Fig.4: Action of the antioxidant 
compounds on theABTS . +  radical, 
after 30 minutes.  
The percentages of inhibition of MPO activity for 
each molecules were calculated versus their 
respective solvent control. Data are given as 
mean ± SD (n≥ 5).                                    ( 
[HRP]=3,41 10-7 M, [H2O2]=4,85 10
-5 M, 
[ABTS]=6,75 10-5 M, in phosphate buffer pH 7.4).  
 
Gallic acid and quercetin exhibit a dose-
dependent action on the formation of 
the ABTS radical state. The association 
of their anti-catalytic and their 
important reducing actions, due to their 
number of hydroxyl groups and their 
stabilization by electronic resonance, 
allow them to increase their action with 
time. 
 
Morphine and ascorbic acid cause a 
reduction of the ABTS+. formation at 
high concentration. After 30 minutes, no 
significant effect can be observed, 
except at 5 10-4 M.  
 
Fig. 7: the solution obtained by the docking 
of morphine in the active site of MPO. 
Docking program: GOLD 
  
Fig. 8: The two solutions 
obtained by the docking of 
propofol in the active site of 
MPO. Docking program: GOLD 
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Fig. 5: Protective 
action of morphine 
against the 
oxidation of ABTS 
by the peroxidase 
cycle of MPO.                      







Morphine and propofol act as reductive substrates in the peroxidase cycle of 
MPO. They enter in competition with ABTS and therefore inhibit its oxidation 
by compound I and compound II. The activity of morphine is dose-dependent, 
in contrast to PPF, which inhibits totally the formation of the radical ABTS+. at 
all three concentrations. These results shows the ability of morphine and PPF 
to enter the active site of MPO, to interact with the enzyme peroxidase 
intermediates. Therefore, a part of both molecules can potentially be attributed 
to their steric effect inside the heme cavity. 
 
The 3D structure of morphine doesn’t 
allow the molecule to enter deep in the 
active site of MPO, to bond with important 
amino acids, like His 95 and therefore to 
inhibits  the enzyme catalytic action.  
The small size and the planar structure of 
propofol allows the molecule to enter the 
heme cavity and to get close to the heme. 
This observation is in agreement with the 
EPR results, demonstrating the potent 
reductive action on MPO peroxidase 
cycle. However, the two dimethyl groups 
don’t allow  the molecule to be correctly 
positioned to build bonds  with important 
active site amino acids, like His 95, which 
intervenes in the trigger of MPO 
peroxidase cycle. Therefore, PPF doesn’t 
seem to be able to present an anti-catalytic 
action.   
EPR spectroscopy allows to demonstrate the antioxidant property of propofol and 
morphine. These two molecules react as reductive substrate in the peroxidase cycle 
of both enzymes, MPO and HRP. Indeed, the association of EPR and molecular 
modeling confirms the ability of the molecules to enter peroxidase active site. 
However, the docking study suggests the absence of strong bonds with important 
amino acids and therefore of anti-catalytic action. This hypothesis has to be confirmed 
via the SIEFED technique.  The stronger action of PPF versus morphine can partially be 
attributed to the greater electronic stabilization of  the PPF radical state. However, 
the absence of a dose-dependent action has still to be explained. 
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The presence of propofol decrease the ABTS+. concentration by more than 90 %, until the lowest 
concentration 10-6 M. The action of PPF is an association of a reductive action on ABTS+. and on the 
HRP cycle. This activity is stable in time thanks to the electronic stabilization of the PPF radical state. 
However, propofol loses 77% of its action at 10-5 M. 
Fig. 6: Protective 
action of propofol 
against the 
oxidation of ABTS 
by the peroxidase 
cycle of MPO.                      
( [MPO]=1.7 10-2M, 
[H2O2]=2.410
-4M, 
[NaNO2]=5 10
-3 M, 
[ABTS]=3.74 10-4 
M).  
